Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Business

British shares drop as lockdowns strain mining stocks; AstraZeneca weighs

2021 01 27T082737Z 1 LYNXMPEH0Q0FT RTROPTP 4 BRITAIN LSE DEATH 1 - Global Banking | Finance

By Shashank Nayar and Amal S

(Reuters) – London listed shares ended lower on Wednesday, led by a decline in mining shares as a surge in virus cases and movement curbs raised demand worries, while Fresnillo slumped after the precious metals miner predicted lower gold production.

The blue-chip FTSE 100 index fell 1.3%, with miners and construction stocks falling the most, while AstraZeneca was the top drag to the index, falling nearly 2.2%.

“There were a few positive factors last year that helped to push equity markets higher, but that energy seems to be fading with rising virus cases and lockdowns being a drag on investor sentiment,” said Craig Erlam, an analyst at Oanda.

British Prime Minister Boris Johnson indicated the COVID-19 lockdown in England would last until March 8, and was set to announce new tougher border measures to stop new variants of COVID-19 getting into the country.

Mining heavy-weights Rio Tinto and Anglo American also weighed on the FTSE 100, while zinc prices fell to their lowest in more than two months as stockpiles climbed and demand in top consumer China weakened. [METL/]

British retailers slipped 0.3% after reporting the biggest annual drop in prices since May, adding to signs of pressure on the sector.

The mood further dampened as Britain’s death toll from the coronavirus pandemic passed 100,000.

The FTSE 100 has recorded consistent monthly gains since November on expectations of a vaccine-led recovery, but it has lost steam as extended lockdowns and worries of vaccine roll-outs hit business activity.

Tullow Oil dropped 12.2% even after the oil exploration company forecast its operating cashflow to reach $500 million in 2021, if the oil price stays above $50 a barrel.

Fresnillo Plc tumbled 13% after forecasting lower gold output for the current year than pandemic-hit 2020, mainly after a land slip at one of its mines in Mexico restricted operations.

(Reporting by Shashank Nayar in Bengaluru; Editing by Arun Koyyur, Sherry Jacob-Phillips and Alex Richardson)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post